Edition:
United States

People: Henry Schein Inc (HSIC.OQ)

HSIC.OQ on NASDAQ Stock Exchange Global Select Market

71.42USD
17 Jun 2019
Change (% chg)

-- (--)
Prev Close
$71.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
625,232
52-wk High
$91.35
52-wk Low
$56.58

Herring, Joseph 

Mr. Joseph L. (Joe) Herring is Independent Director of the Company. From 2005 to 2015, From 2005 to 2015, Mr. Herring served as Chief Executive Officer of Covance Inc., a drug development services company, and as Chairman of the Board of Directors of Covance from 2006 until its acquisition by Laboratory Corporation of America, Inc. in 2015. Mr. Herring previously served in several executive roles with Covance, including President and Chief Operating Officer, President of Early Development Services and Corporate Vice President and General Manager for its North American Preclinical Operations. Prior to joining Covance, Mr. Herring held a variety of senior leadership positions with Caremark International and American Hospital Supply Corporation over the course of his 19 years with the combined companies. The Company’s Board of Directors values Mr. Herring’s more than 35 years of experience in the healthcare industry. Mr. Herring also brings to the Company’s Board of Directors comprehensive knowledge in pharmaceuticals, management, sales and corporate governance matters. Mr. Herring currently serves on the nonprofit board for University Medical Center of Princeton and previously served on the board of the Association of Clinical Research Organizations, of which he served as chairman. During the past five years, Mr. Herring served as a director of Covance Inc. and Team Health Holdings Inc.

Basic Compensation

Total Annual Compensation, USD 106,000
Restricted Stock Awards, USD 185,400
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 291,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --